Journal of Yeungnam Medical Science

Review article

Psychiatry and Mental Health
Advances, challenges, and prospects of electroencephalography-based biomarkers for psychiatric disorders: a narrative review: Seokho Yun; J Yeungnam Med Sci. 2024;41(4):261-268. Published online September 9, 2024; DOI: https://doi.org/10.12701/jyms.2024.00668

4,236 View
113 Download
3 Web of Science
4 Crossref

Owing to a lack of appropriate biomarkers for accurate diagnosis and treatment, psychiatric disorders cause significant distress and functional impairment, leading to social and economic losses. Biomarkers are essential for diagnosing, predicting, treating, and monitoring various diseases. However, their absence in psychiatry is linked to the complex structure of the brain and the lack of direct monitoring modalities. This review examines the potential of electroencephalography (EEG) as a neurophysiological tool for identifying psychiatric biomarkers. EEG noninvasively measures brain electrophysiological activity and is used to diagnose neurological disorders, such as depression, bipolar disorder (BD), and schizophrenia, and identify psychiatric biomarkers. Despite extensive research, EEG-based biomarkers have not been clinically utilized owing to measurement and analysis constraints. EEG studies have revealed spectral and complexity measures for depression, brainwave abnormalities in BD, and power spectral abnormalities in schizophrenia. However, no EEG-based biomarkers are currently used clinically for the treatment of psychiatric disorders. The advantages of EEG include real-time data acquisition, noninvasiveness, cost-effectiveness, and high temporal resolution. Challenges such as low spatial resolution, susceptibility to interference, and complexity of data interpretation limit its clinical application. Integrating EEG with other neuroimaging techniques, advanced signal processing, and standardized protocols is essential to overcome these limitations. Artificial intelligence may enhance EEG analysis and biomarker discovery, potentially transforming psychiatric care by providing early diagnosis, personalized treatment, and improved disease progression monitoring.

Citations

Citations to this article as recorded by

Zipper Pattern: An Investigation into Psychotic Criminal Detection Using EEG Signals
Gulay Tasci, Prabal Datta Barua, Dahiru Tanko, Tugce Keles, Suat Tas, Ilknur Sercek, Suheda Kaya, Kubra Yildirim, Yunus Talu, Burak Tasci, Filiz Ozsoy, Nida Gonen, Irem Tasci, Sengul Dogan, Turker Tuncer
Diagnostics.2025; 15(2): 154. CrossRef
Innovative Therapeutic Approaches in Severe Adolescent Depression: Neuroimaging and Pharmacological Insights
Andrei-Gabriel Zanfir, Simona-Corina Trifu
Balneo and PRM Research Journal.2025; 16(Vol 16 No.): 765. CrossRef
Epileptic Seizure Detection Using Machine Learning: A Systematic Review and Meta-Analysis
Lin Bai, Gerhard Litscher, Xiaoning Li
Brain Sciences.2025; 15(6): 634. CrossRef
A Systematic Review of Mental Health Monitoring and Intervention Using Unsupervised Deep Learning on EEG Data
Akhila Reddy Yadulla, Guna Sekhar Sajja, Santosh Reddy Addula, Mohan Harish Maturi, Geeta Sandeep Nadella, Elyson De La Cruz, Karthik Meduri, Hari Gonaygunta
Psychology International.2025; 7(3): 61. CrossRef

Original article

Psychiatry and Mental Health
Impact of COVID-19 on the development of major mental disorders in patients visiting a university hospital: a retrospective observational study: Hee-Cheol Kim; J Yeungnam Med Sci. 2024;41(2):86-95. Published online February 6, 2024; DOI: https://doi.org/10.12701/jyms.2023.01256

2,554 View
75 Download

Abstract PDF: Background
This study aimed to investigate the impact of coronavirus disease 2019 (COVID-19) on the development of major mental disorders in patients visiting a university hospital.
Methods
The study participants were patients with COVID-19 (n=5,006) and those without COVID-19 (n=367,162) registered in the database of Keimyung University Dongsan Hospital and standardized with the Observational Medical Outcomes Partnership Common Data Model. Data on major mental disorders that developed in both groups over the 5-year follow-up period were extracted using the FeederNet computer program. A multivariate Cox proportional hazards model was used to estimate the hazard ratio (HR) and 95% confidence interval (CI) for the incidence of major mental disorders.
Results
The incidences of dementia and sleep, anxiety, and depressive disorders were significantly higher in the COVID-19 group than in the control group. The incidence rates per 1,000 patient-years in the COVID-19 group vs. the control group were 12.71 vs. 3.76 for dementia, 17.42 vs. 7.91 for sleep disorders, 6.15 vs. 3.41 for anxiety disorders, and 8.30 vs. 5.78 for depressive disorders. There was no significant difference in the incidence of schizophrenia or bipolar disorder between the two groups. COVID-19 infection increased the risk of mental disorders in the following order: dementia (HR, 3.49; 95% CI, 2.45–4.98), sleep disorders (HR, 2.27; 95% CI, 1.76–2.91), anxiety disorders (HR, 1.90; 95% CI, 1.25–2.84), and depressive disorders (HR, 1.54; 95% CI, 1.09–2.15).
Conclusion
This study showed that the major mental disorders associated with COVID-19 were dementia and sleep, anxiety, and depressive disorders.

First
Prev
Page of 1
Next
Last

Search